Cerebrospinal fluid parameters influencing the outcome of Cryptococcal meningitis: Indian experience



  • Ravindra Nath Sahay

    Seth G S Medical College & KEM Hospital , Parel, Mumbai, Maharashtra

  • Kavita S Joshi

    Seth G S Medical College & KEM Hospital, Parel, Mumbai, Maharashtra

  • Amar P Pandit

    Topiwala National Medical College, Mumbai

  • Kavita J Rawat

    Seth G S Medical College & KEM Hospital, Parel, Mumbai, Maharashtra




Offloading, Diabetic foot ulcer, Mandakini offloading device, Samadhan offloading system


Purpose: Incidence of Cryptococcal meningitis (CM) is increasing as prevalence of HIV, long term steroids use and organ transplant increase. The study was done to analyze demographic, clinical and biochemical parameters and to correlate these parameters with mortality. Materials and Method: 50 patients of CM, diagnosed on the basis of India ink positivity, Cryptococcal antigen or Culture. Patients were followed up till discharge or death. Results: Out of the 50 patients, 45 patients were HIV positive. Headache was the most common symptom (100%), followed by vomiting, fever, and altered sensorium, blindness, seizures, diplopia and psychiatric symptoms. The factors associated with a greater risk for mortality were CD4 ≤ 50 cells/ cu.mm (p=0.012), low GCS ≤ 8 (p=0.000011), blindness (p =0.034), papilledema (p=0.0009) and low CSF sugar (p=0.0005). There was an association between high CSF pressure (>30 cm of H2O) and blindness (p=0.005). Other factors which were associated with a higher trend of mortality but not significant were associated tuberculosis and high CSF pressure. Conclusions: Mortality associated with CM continues to be high in spite of availability of medications. Factors associated with high mortality were low initial CD4, lower GCS at presentation, blindness, papilledema and low CSF sugar.


Download data is not yet available.

Author Biographies

Ravindra Nath Sahay, Seth G S Medical College & KEM Hospital , Parel, Mumbai, Maharashtra

Associate Professor , Department of Medicine

Kavita S Joshi, Seth G S Medical College & KEM Hospital, Parel, Mumbai, Maharashtra

Associate Professor , Department of Medicine

Amar P Pandit, Topiwala National Medical College, Mumbai

Assistant Professor, Department of Medicine

Kavita J Rawat, Seth G S Medical College & KEM Hospital, Parel, Mumbai, Maharashtra

Associate Professor , Department of Medicine


UNICEF. Opportunity in crisis: Preventing HIV from early adolescence to young adulthood. June 2011, available at http://www.unicef.org/media/files/ Opportunity_in_Crisis_LoRes_EN_05182011.pdf [accessed 16 Jan 2017].

Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. Aids. 2009 Feb 20; 23(4):525-30.

Pappas PG. Cryptococcosis in the developing world: An elephant in the parlor. Clin Infect Dis. 2010; 50:345–6.

Juhi T, BibhaBati M, Aradhana B, Poonam L, Vinita D, Archana T. Cryptococcal Meningitis in a Tertiary Care Hospital. Jpn J Med Mycol 2009; 50(2):95-9.

Chariyalertsak S, Sirisanthana T, Saengwonloey O, Nelson KE. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994–1998: regional variation and temporal trends. Clin Infect Dis 2001; 32(6):955-62.

Jaiswal S P, Hemwani N, Sharma N, Athale S, Chitnis D S. Prevalence of fungal meningitis among HIV positive & negative subjects in Indore (MP State). Indian J Med Sci 2002; 56:325-9.

Subramanian S, Mathai D. Clinical manifestations and management of cryptococcal infection. J Postgrad Med 2005; 51:21-6.

Prasad KN, Agarwal J, Nag VL, Verma AK, Dixit AK, Ayyagari A. Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol India 2003; 51(3):364-6.

Majumder S, Mandal SK, Bandyopadhyay D. Prognostic markers in AIDS-related cryptococcal meningitis. J Assoc Physicians India 2011; 59:152-4.

Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. QJM 2000; 93(4):245-51.

Satishchandra P, Mathew T, Gadre G, Nagarathna S, Chandramukhi A, Mahadevan A et al. Cryptococcal meningitis: clinical, diagnostic and therapeutic overviews. Neurol India 2007; 55(3):226-32.

Liao CH, Chi CY, Wang YJ, Tseng SW, Chou CH, Ho CM et al. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis. J Microbiol Immunol Infect 2012; 45(4):296-304.

Khanna N, Chandramuki A, Desai A, Ravi V. Cryptococcal infections of the central nervous system: an analysis of predisposing factors, laboratory findings and outcome in patients from South India with special reference to HIV infection. J Med Microbiol 1996; 45(5):376-9.

Harris JR, Lockhart SR, Debess E, Marsden-Haug N, Goldoft M, Wohrle R et al. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis 2011; 53(12):1188-95.

Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 2010; 50(3):291-322.

Ives NJ, Gazzard BG, Easterbrook PJ. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect 2001; 42(2):134-9.

Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker LG et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with Amphotericin B or Fluconazole. Clin Infect Dis 2007; 45(1):76-80.

Chottanapund S, Singhasivanon P, Kaewkungwal J, Chamroonswasdi K, Manosuthi W. Survival time of HIV-infected patients with cryptococcal meningitis. J Med Assoc Thai 2007; 90(10):2104-11.

Kumar S, Wanchu A, Chakrabarti A, Sharma A, Bambery P, Singh S. Cryptococcal meningitis in HIV infected: experience from a North Indian tertiary center. Neurol India 2008; 56(4):444-9.

Rex JH, Larsen RA, Dismukes WE, Cloud GA, Bennett JE. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine (Baltimore) 1993; 72(4):207-24.

Pitisuttithum P, Tansuphasawadikul S, Simpson AJ, Howe PA, White NJ. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B. J Infect 2001; 43(4):226-33.

Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med 1974; 80(2):176-81.

Popovich MJ, Arthur RH, Helmer E. CT of intracranial cryptococcosis. AJR Am J Roentgenol 1990; 154(3):603-6.

Sachdeva RK, Randev S, Sharma A, Wanchu A, Chakrabarti A, Singh S et al. A retrospective study of AIDS-associated cryptomeningitis. AIDS Res Hum Retroviruses 2012; 28(10):1220-6.

Kendi C, Penner J, Koech J, Nyonda M, Cohen CR, Bukusi EA et al. Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings. Postgrad Med J 2013; 89(1048):73-7.

Mathiesen IH, Knudsen JD, Gerstoft J, Cowan S, Benfield T. Outcome of HIV-1-associated cryptococcal meningitis, Denmark 1988-2008. Scand J Infect Dis 2012; 44(3):197-200.



How to Cite

Sahay RN, Joshi KS, Pandit AP, Rawat KJ. . Int Jour of Biomed Res [Internet]. 2017Feb.28 [cited 2020Jun.1];8(2):97-102. Available from: https://ssjournals.net/index.php/ijbr/article/view/3931


Vol. 8 No. 2 (2017): Feb


Original Research Articles

Dr. Jun Ren is a dedicated and experienced registered dietitian and nutritionist who is committed to helping people achieve their health goals through personalized nutrition plans. With a passion for promoting healthy eating habits and preventing chronic diseases, Dr. Ren has been able to assist numerous clients in improving their overall quality of life.

Leave a Comment